Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury

Journal of Gene Medicine

Volumn 2, Issue 5, 2000, Pages 326-333

  Brocheriou, Valérie ^a   Hagège, Albert A ^b   Oubenaïssa, Abdou ^c   Lambert, Martine ^a   Mallet, Vincent O ^a   Duriez, Micheline ^c   Wassef, Michel ^c   Kahn, Axel ^a   Menasché, Philippe ^d   Gilgenkrantz, Hélène ^a  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

Apoptosis; bcl 2; Echocardiography; Myocardial infarction; Reperfusion

Indexed keywords

ANIMALIA; MUS MUSCULUS;

ANIMAL; APOPTOSIS; ARTICLE; DISEASE MODEL; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE THERAPY; GENETICS; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HUMAN; METHODOLOGY; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PROTO ONCOGENE; REPERFUSION INJURY; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE THERAPY; GENES, BCL-2; HUMANS; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; VENTRICULAR FUNCTION, LEFT;

EID: 0010034895     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-2254(200009/10)2:5<326::AID-JGM133>3.0.CO;2-1     Document Type: Article

References (32)

1. Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 1997; 100: 1363-1372.
2. Fliss H. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79: 949-956.
3. Itoh G. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 1995; 146: 1325-1331.
4. Narula J, Haider R, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-1189.
5. Olivetti G. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1994; 28: 2005-2016.
6. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-1141.
7. Saraste A, Pulkki K, Kallajok IM, Henriksen K, Parvinen M, Voipio-Pukk L-M. Apoptosis in human acute myocardial infarction. Circulation 1997; 95: 320-323.
8. Ma XL, Kumar S, Gao F, et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999; 99: 1685-1691.
9. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A 1995; 92: 8031-8035.
10. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998; 97: 276-281.
11. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000; 101: 660-667.
12. Lacronique V, Mignon A, Fabre M, et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 1996; 2: 80-86.
13. Cox GA, Cole NM, Matsumura K, et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 1993; 364: 725-729.
14. Michael LH, Entman ML, Hartley CJ, et al. Myocardial ischemia and reperfusion: a murine model. Am J Physiol 1995; 269: H2147-H2154.
15. Young H, Rokosh G, Lester S, Simpson P, Schiller N, Foster E. Two-dimensional echocardiography with a 15-MHz transducer is a promising alternative for in vivo measurement of left ventricular mass in mice. J Am Soc Echocardiogr 1999; 12: 70-75.
16. Maulik N, Engelman RM, Rousou JA, Flack JE, Deaton D, Das DK. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 1999; 100: H369-H375.
17. Saikumar P, Dong Z, Patel Y, et al. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 1998; 17: 3401-3405.
18. Saikumar P, Dong Z, Weinberg J, Venkatachalam M. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 1998; 17: 3341-3349.
19. Shimizu S, Eguchi Y, Kamiike W, et al. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 1996; 12: 2045-2050.
20. Subramanian T, Tarodi B, Chinnadurai G. p53-Independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B19K and Bcl-2 proteins. Cell Growth Differ 1995; 652: 131-137.
21. Bilbao G, Contreras J, Gomez-Navarro J, et al. Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation. Transplantation 1999; 67: 775-778.
22. Wang P, Chen H, Qin H, et al. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci U S A 1998; 95: 4556-4560.
23. Hockenbery D, Oltvai Z, Yin X, Milliman C, Korsmeyer S. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251.
24. Kane D, Ord T, Anton R, DEB. Expression of Bcl-2 inhibits necrotic neural cell death. J Neurosci Res 1995; 40: 269-275.
25. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c blocked. Science 1997; 275: 1129-1132.
26. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria., a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-1136.
27. Saikumar P, Dong Z, Patel Y, et al. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 1998; 17: 3401-3415.
28. Zhivotovsky B, Orrenius S, Brustugun O, Doskeland SO. Injected cytochrome c induces apoptosis. Nature 1998; 391: 441-442.
29. Yue T-L, Ma X-L, Wang X, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 1998; 82: 166-174.
30. Yang X, Khosravi-Far R, Chang H, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997; 89: 1067-1076.
31. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, et al. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38 mitogen-activated protein kinases and c-Jun N-terminal kinase are activated by ischemia/reperfusion. Circ Res 1996; 79: 162-173.
32. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T. The stress-activated protein kinases are major c-jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 1994; 269: 26546-26551.